PA Attorney General files lawsuit claiming pharmaceutical companies 'manipulated insulin price markets'

3 articles, oldest first.

1. We Are Central PA

   PA files lawsuit against pharmaceuticals, benefit mangers over inflated insulin prices ↗ (opens We Are Central PA)

   Published Oct 13, 2026

   We Are Central PA's feed description

   PENNSYLVANIA (WTAJ) — A lawsuit has been filed against several pharmaceutical companies and pharmacy benefit managers (PBMs) regarding collusion to manipulate insulin price markets. The Office of Attorney General's Antitrust Section filed the complaint this week alleging violations of Pennsylvania's…

2. PhillyVoice

   Pennsylvania sues pharma companies for allegedly colluding to manipulate insulin prices ↗ (opens PhillyVoice)

   Published Oct 13, 2026

   PhillyVoice's feed description

   Attorney General Dave Sunday is seeking restitution for diabetic Pennsylvanians harmed by inflated insulin prices in a new lawsuit against drug manufacturers like Eli Lilly and pharmacy benefit managers like Caremark and OptumRx.

3. ABC 27 Harrisburg

   PA Attorney General files lawsuit claiming pharmaceutical companies 'manipulated insulin price markets' ↗ (opens ABC 27 Harrisburg)

   Published Oct 13, 2026

   ABC 27 Harrisburg's feed description

   HARRISBURG, Pa. (WHTM) -- Pennsylvania Attorney General Dave Sunday is accusing multiple drug makers and pharmacy benefit managers of conspiring to increase insulin prices. In a lawsuit announced Tuesday, the office says the companies schemed to artificially increase prices by more than 10 times the…